在患有慢性病的高尿血患者中,多提努拉德可以恢复恶化的功能障碍
Hoichi Amano1, Seiji Kobayashi1, Hiroyuki Terawaki2,3
1Department of Nephrology, Teikyo University Chiba Medical Center, Chiba, Japan.
在患有慢性病和高尿血症的患者中,多提努拉德治疗改善了功能. 这种尿酸降低疗法显示出预防进一步衰退的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 和高尿素血 (HUA) 是常见的疾病.
- 血清尿酸盐水平升高 (sUA) 可能会对功能产生负面影响.
研究的目的:
- 评估新型尿酸降低剂多提努拉德 (dotinurad) 在患有HUA的CKD患者中改善功能方面的疗效.
主要方法:
- 一项涉及35名患有HUA的CKD患者的研究.
- 患者接受了为期3个月的观察期,随后接受了为期3个月的多提努拉德治疗.
- 监测了估计的膜过率 (eGFR) 和sUA水平的变化.
主要成果:
- 在观察期间,eGFR显著下降.
- 多提努拉德治疗导致EGFR恢复 (从31.8到36.5毫升/分钟/1.73米2),并减少sUA (从8.1到6.7毫克/分升).
- 增加的eGFR与减少的sUA相关 (R=0.375,p=0.0263).
结论:
- 多提努拉德的使用似乎有利于恢复HUA的CKD患者的功能.
- 多提努拉德显示出作为预防HUA诱导功能下降的治疗选择的潜力.
更多相关视频
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Antihypertensive Drugs: Action of Diuretics
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: Diuretics
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Dipeptidyl Peptidase 4 Inhibitors
